{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:53:00Z","timestamp":1781657580764,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82073131"],"award-info":[{"award-number":["No. 82073131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81870525"],"award-info":[{"award-number":["No.81870525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No. tsqn201909199"],"award-info":[{"award-number":["No. tsqn201909199"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["no. ZR2022MH261"],"award-info":[{"award-number":["no. ZR2022MH261"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["no. ZR2021MH185"],"award-info":[{"award-number":["no. ZR2021MH185"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1283"],"award-info":[{"award-number":["ZR2025MS1283"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yantai Science and Technology Innovation Development Plan","award":["grant no. 2022JCYJ040"],"award-info":[{"award-number":["grant no. 2022JCYJ040"]}]},{"name":"2025 Yantai Natural Science Foundation for Biomedical Innovation Joint Fund Project","award":["2025YT06001521"],"award-info":[{"award-number":["2025YT06001521"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06102-7","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:07:45Z","timestamp":1777457265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircGRHL2 suppresses EMT and enhances sunitinib sensitivity in ccRCC via the miR-330-5p\/FBXO21 axis"],"prefix":"10.1007","volume":"83","author":[{"given":"Jie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-3923","authenticated-orcid":false,"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"6","key":"6102_CR1","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/ijgc-2024-005457","volume":"34","author":"E Silva","year":"2024","unstructured":"Silva E (2024) Cancer statistics, 2024: mixed results in gynecologic oncology. Int J Gynecol Cancer 34(6):964","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"6102_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.eururo.2022.10.010","volume":"83","author":"J Bedke","year":"2023","unstructured":"Bedke J, Albiges L, Capitanio U, Giles RH, Hora M, Ljungberg B et al (2023) The 2022 updated European Association of Urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma. Eur Urol 83(1):10\u201314","journal-title":"Eur Urol"},{"issue":"10","key":"6102_CR3","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1084\/jem.20181617","volume":"215","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Swanton C, Boshoff C (2018) Kidney cancer: the next decade. J Exp Med 215(10):2477\u20132479","journal-title":"J Exp Med"},{"issue":"22","key":"6102_CR4","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1200\/JCO.2008.20.1293","volume":"27","author":"RJ Motzer","year":"2009","unstructured":"Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S et al (2009) Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27(22):3584\u20133590","journal-title":"J Clin Oncol"},{"issue":"3","key":"6102_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, Calin GA (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211\u2013232","journal-title":"Nat Rev Genet"},{"key":"6102_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00721-7","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ (2024) Circular rna in cancer. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-024-00721-7","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"6102_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01912-w","volume":"23","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zeng X, Zhu Y, Leng M, Zhang Z, Wang Q et al (2024) CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p\/CYP1B1 axis. Mol Cancer 23(1):4","journal-title":"Mol Cancer"},{"issue":"8","key":"6102_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1339","volume":"13","author":"J Cen","year":"2023","unstructured":"Cen J, Liang Y, Feng Z, Chen X, Chen J, Wang Y et al (2023) Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma. Clin Transl Med 13(8):e1339","journal-title":"Clin Transl Med"},{"key":"6102_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canlet.2021.10.003","volume":"523","author":"KB Huang","year":"2021","unstructured":"Huang KB, Pan YH, Shu GN, Yao HH, Liu X, Zhou M et al (2021) Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184\/GPCPD1\/ lysophosphatidic acid axis. Cancer Lett 523:121\u2013134","journal-title":"Cancer Lett"},{"issue":"1","key":"6102_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10555-023-10162-7","volume":"43","author":"N Ebrahimi","year":"2024","unstructured":"Ebrahimi N, Manavi MS, Faghihkhorasani F, Fakhr SS, Baei FJ, Khorasani FF et al (2024) Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response. Cancer Metastasis Rev 43(1):457\u2013479","journal-title":"Cancer Metastasis Rev"},{"issue":"13","key":"6102_CR11","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1158\/0008-5472.CAN-23-3264","volume":"84","author":"S Yang","year":"2024","unstructured":"Yang S, Zhang D, Sun Q, Nie H, Zhang Y, Wang X et al (2024) Single-cell and spatial transcriptome profiling identifies the transcription factor BHLHE40 as a driver of EMT in metastatic colorectal cancer. Cancer Res 84(13):2202\u20132217","journal-title":"Cancer Res"},{"issue":"1","key":"6102_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02518-0","volume":"22","author":"R Sarkar","year":"2024","unstructured":"Sarkar R, Biswas S, Ghosh R, Samanta P, Pakhira S, Mondal M et al (2024) Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3\u2019-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer. J Nanobiotechnol 22(1):285","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"6102_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ccell.2023.01.007","volume":"41","author":"MB Nilsson","year":"2023","unstructured":"Nilsson MB, Yang Y, Heeke S, Patel SA, Poteete A, Udagawa H et al (2023) CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance. Cancer Cell. 41(2):340\u201355 e6","journal-title":"Cancer Cell."},{"issue":"1","key":"6102_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05236-w","volume":"81","author":"M Ashrafizadeh","year":"2024","unstructured":"Ashrafizadeh M, Dai J, Torabian P, Nabavi N, Aref AR, Aljabali AAA et al (2024) Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance. Cell Mol Life Sci 81(1):214","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"6102_CR15","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1083\/jcb.201812081","volume":"218","author":"YS Bykov","year":"2019","unstructured":"Bykov YS, Cohen N, Gabrielli N, Manenschijn H, Welsch S, Chlanda P et al (2019) High-throughput ultrastructure screening using electron microscopy and fluorescent barcoding. J Cell Biol 218(8):2797\u20132811","journal-title":"J Cell Biol"},{"issue":"3","key":"6102_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J (2022) The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 19(3):188\u2013206","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"6102_CR17","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41375-023-02020-w","volume":"37","author":"KK Dobish","year":"2023","unstructured":"Dobish KK, Wittorf KJ, Swenson SA, Bean DC, Gavile CM, Woods NT et al (2023) FBXO21 mediated degradation of p85alpha regulates proliferation and survival of acute myeloid leukemia. Leukemia 37(11):2197\u20132208","journal-title":"Leukemia"},{"issue":"2","key":"6102_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13306","volume":"20","author":"Z Lin","year":"2021","unstructured":"Lin Z, Miao J, Zhang T, He M, Wang Z, Feng X et al (2021) JUNB-FBXO21-ERK axis promotes cartilage degeneration in osteoarthritis by inhibiting autophagy. Aging Cell 20(2):e13306","journal-title":"Aging Cell"},{"issue":"5","key":"6102_CR19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/jca.49674","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Liu X, Shen R, Gu X, Qian W (2021) Fbxo21 regulates the epithelial-to-mesenchymal transition through ubiquitination of Nr2f2 in gastric cancer. J Cancer 12(5):1421\u20131430","journal-title":"J Cancer"},{"key":"6102_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"X Wang","year":"2023","unstructured":"Wang X, Eichhorn PJA, Thiery JP (2023) TGF-beta, EMT, and resistance to anti-cancer treatment. Semin Cancer Biol 97:1\u201311","journal-title":"Semin Cancer Biol"},{"key":"6102_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115109","volume":"223","author":"L Fang","year":"2019","unstructured":"Fang L, Zhang Y, Zang Y, Chai R, Zhong G, Li Z et al (2019) HP-1 inhibits the progression of ccRCC and enhances sunitinib therapeutic effects by suppressing EMT. Carbohydr Polym 223:115109","journal-title":"Carbohydr Polym"},{"key":"6102_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032512","author":"Z Wang","year":"2023","unstructured":"Wang Z, Coban B, Liao CY, Chen YJ, Liu Q, Danen EHJ (2023) GRHL2 regulation of growth\/motility balance in luminal versus basal breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032512","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6102_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41417-024-00745-z","volume":"31","author":"L Yang","year":"2024","unstructured":"Yang L, Kumegawa K, Saeki S, Nakadai T, Maruyama R (2024) Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer Gene Ther 31(5):736\u2013745","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"6102_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41420-023-01582-z","volume":"9","author":"J Zhong","year":"2023","unstructured":"Zhong J, Xu A, Xu P, Su M, Wang P, Liu Z et al (2023) Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p. Cell Death Discov 9(1):283","journal-title":"Cell Death Discov"},{"issue":"3-4","key":"6102_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41417-020-00215-2","volume":"28","author":"S Xu","year":"2021","unstructured":"Xu S, Lei SL, Liu KJ, Yi SG, Yang ZL, Yao HL (2021) CircSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p\/PAK1 axis. Cancer Gene Ther 28(3\u20134):234\u2013249","journal-title":"Cancer Gene Ther"},{"issue":"1\u20132","key":"6102_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11010-020-03778-8","volume":"471","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Xie Y, Wang L, Xu T, Gao Y (2020) LncRNA EWSAT1 upregulates CPEB4 via miR-330-5p to promote cervical cancer development. Mol Cell Biochem 471(1\u20132):177\u2013188","journal-title":"Mol Cell Biochem"},{"key":"6102_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106818","volume":"193","author":"W Wang","year":"2023","unstructured":"Wang W, Zhu L, Zhou J, Liu X, Xiao M, Chen N et al (2023) Targeting the KRT16-vimentin axis for metastasis in lung cancer. Pharmacol Res 193:106818","journal-title":"Pharmacol Res"},{"key":"6102_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100929","volume":"67","author":"J Jin","year":"2023","unstructured":"Jin J, Xie Y, Zhang JS, Wang JQ, Dai SJ, He WF et al (2023) Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers. Drug Resist Updat 67:100929","journal-title":"Drug Resist Updat"},{"issue":"13","key":"6102_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215132120","volume":"120","author":"S Chen","year":"2023","unstructured":"Chen S, Li K, Guo J, Chen HN, Ming Y, Jin Y et al (2023) CircNEIL3 inhibits tumor metastasis through recruiting the E3 ubiquitin ligase Nedd4L to degrade YBX1. Proc Natl Acad Sci U S A 120(13):e2215132120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6102_CR30","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.1038\/s41467-023-42571-1","volume":"14","author":"K Li","year":"2023","unstructured":"Li K, Guo J, Ming Y, Chen S, Zhang T, Ma H et al (2023) A circular RNA activated by TGFbeta promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability. Nat Commun 14(1):6876","journal-title":"Nat Commun"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06102-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06102-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06102-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:01:11Z","timestamp":1781654471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06102-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6102"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06102-7","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mice used in this study were purchased from Shanghai Slac Laboratory Animal Co. Ltd. All animal experiments were performed in accordance with the guidelines issued by Qingdao University for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}